Amyris Inc (AMRS) 3.09 $AMRS
Why Amyris Inc's Shares Popped Today
Travis Hoium, The Motley Fool - Motley Fool - Fri May 09, 5:24PM CDT
Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis. What: Shares of renewable products company Amyris Inc ...
Amyris Reports First Quarter 2014 Financial Results
GlobeNewswire - Thu May 08, 3:48PM CDT
-- Strong operating performance with combined inflows from product sales and collaboration inflows of $17.9 million
Amyris Receives Roundtable on Sustainable Biomaterials (RSB) Sustainability Certification
GlobeNewswire - Wed May 07, 9:14AM CDT
Amyris, Inc. (Nasdaq:AMRS) has completed the Roundtable on Sustainable Biomaterials (RSB) certification process and has earned one of the most respected sustainability certifications in the world.
What Will Amyris Gain and Sacrifice to Court Tire Manufacturers for Expansion?
Maxx Chatsko, The Motley Fool - Motley Fool - Thu May 01, 1:00PM CDT
A worker stands next to 200,000 liter fermenters at a biorefinery in Brotas, Brazil. Source: Amyris I recently introduced the opportunity presented by the tire industry for the synthetic biology platform under development by Amyris and partner...
Amyris Helps Launch Brazilian Industrial Biotech Association
GlobeNewswire - Wed Apr 30, 4:14PM CDT
A group of the world's leading industrial biotechnology companies, including Amyris (Nasdaq:AMRS), joined forces yesterday to form the Brazilian Industrial Biotechnology Association (in Portuguese ABBI - Associacão Brasileira de Biotecnologia Industrial). This new trade association brings together companies and institutions developing and using microorganisms and its derivatives to deliver renewable products for industries and consumers worldwide. ABBI's primary objective is to foster a dialogue within Brazilian society about the advancements of industrial biotechnology in Brazil. The founding members of ABBI are Amyris, BASF, BioChemtex, BP, Centro de Tecnologia Canavieira, Dow, DSM, DuPont, GranBio, Novozymes, Raizen and Rhodia.
Amyris Is Giving the "Hippie Perfume Molecule" a Synthetic Biology Makeover
Maxx Chatsko, The Motley Fool - Motley Fool - Thu Apr 24, 10:15AM CDT
The patchouli plant, grown for centuries in tropical Asia for use in perfumes, is due for a makeover. Source: Wikimedia Commons / Vieux jardin botanique de Göttingen . Patchouli is fun to say and more fun to spray. While Urban Dictionary...
Amyris to Announce First Quarter Financial Results on Thursday, May 8, 2014
GlobeNewswire - Wed Apr 23, 7:01AM CDT
Amyris, Inc. (Nasdaq:AMRS) will report financial results for the first quarter ended March 31, 2014 after market close on Thursday, May 8, 2014.
Global Synthetic Biology Market 2013-2019 - Genome Engineering, DNA Sequencing, Bioinformatics & Biological Components and Integrated Systems
M2 - Tue Apr 22, 5:30AM CDT
Research and Markets (http://www.researchandmarkets.com/research/29nxfg/synthetic_biology) has announced the addition of the "Synthetic Biology Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast,2013 - 2019" report to their offering. Synthetic biology is a synergistic combination of biology and engineering for the construction of artificial biological system in order to gain desired functions (i.e. to reduce cost or improve efficacy). It comprises nascent technologies that enable synthesis of novel biological parts and organisms that are used in the field of healthcare, chemicals, agriculture and others (biosecurity, R&D and energy and environment). The synthetic biology market is witnessing rapid growth owing to increase in demand for renewable fuels and bio-based chemicals and inexpensive drugs and vaccines that utilizes synthetic biology technologies and products. In addition, participation of various organizations such as BioBricks, DIYbio and SynBERC, for the development of synthetic biology field will further augment the growth of this market during the forecast period. However, high cost and strict regulations to use synthetic biology techniques hampers the growth of this market. Synthetic biology market is segmented mainly by products, by technologies and by applications. Synthetic biology, by product segment is classified as core products and enabling products. Core products are further segmented into synthetic DNA, synthetic genes, synthetic cells, XNA and chassis organisms. The synthetic biology market by core products was dominated by synthetic DNA market in 2012 owing to the commercial availability of this product, compared to other synthetic core products expected to be launched in the market in coming years. Synthetic biology market by technologies is segmented as genome engineering, DNA sequencing, bioinformatics and biological components and integrated systems. Genome engineering technology can be used to modify genetic foods, gene cloning and gene therapy. Thus, application of genome engineering increases the scope to utilize this technique and hence accentuates the growth of this market. Applications of synthetic biology are healthcare, chemicals, agriculture and others. Synthetic biology in healthcare holds largest market share in terms of revenue due to high utilization of synthetic biology techniques to produce cheap drugs and vaccines. Also, commercial availability of synthetic DNA and synthetic genes supports the growth of the healthcare application in the synthetic biology market. Agriculture segment is expected to grow at the highest growth rate during the forecast period. The global synthetic biology market is segmented into the following categories: Products - Core Products - - Synthetic DNA - - Synthetic Genes - - Synthetic Cells - - XNA (Xeno Nucleic Acid) - - Chasis Organisms - Enabling Products - - DNA Synthesis - - Oligonucleotide Synthesis Technologies - Genome Engineering - DNA Sequencing - Bioinformatics - Biological Components and Integrated Systems Applications - Healthcare - Chemicals (Including Bio-Fuels) - Agriculture - Others (Biosecurity, R&D, Energy and Environment) Key Topics Covered: - Introduction - Executive Summary - Market Overview - Global Synthetic Biology Market, by Products - Global Synthetic Biology Market, by Technologies - Global Synthetic Biology Market, by Applications - Global Synthetic Biology Market, by Geography - Competitive Landscape - Recommendations - Company Profiles - Agrivida, Inc. - Amyris, Inc. - Algenol Biofuels, Inc. - ATG:biosynthetics GmbH - Bayer AG - Bristol-Myers Squibb - BIONEER CORPORATION - Biosearch Technologies, Inc. - CBC Comprehensive Biomarker Center GmbH - Cobalt Technologies - DuPont, Inc. - Evolva SA - Exxon Mobil Corporation - Ginkgo Bioworks - GeneWorks Pty Ltd. - Genomatica, Inc. - GeneScript Corporation - Gevo, Inc. - Green Biologics Limited - New England Biolabs, Inc. - OriGene Technologies, Inc. - REG Life Sciences, LLC - Royal DSM - Thermo Fisher Scientific, Inc. For more information visit http://www.researchandmarkets.com/research/29...ic_biology
Solazyme and Amyris Can Cut Energy Consumption Without Producing a Drop of Fuel
Maxx Chatsko, The Motley Fool - Motley Fool - Sun Apr 20, 12:03PM CDT
Most companies targeting renewable fuels failed fast and hard after the Great Recession, which caused oil prices to plummet from an all-time high of $147 per barrel in July 2008 to a several-year minimum below $40 per barrel in 2009. Oil prices have...
The World's Leading Tire Manufacturers Are Turning to Synthetic Biology -- But Not for the Reason Yo
Maxx Chatsko, The Motley Fool - Motley Fool - Wed Apr 16, 11:45AM CDT
This pile of 1 million tires would produce 55,000 gallons of toxic oil runoff into the environment if set ablaze. Source: Ohio EPA. The U.S. Environmental Protection Agency has made tremendous strides in reducing scrap tire stockpiles in the past...
Rising World Food Prices Spell Trouble for Biofuels
Shamus Funk, The Motley Fool - Motley Fool - Wed Apr 16, 8:43AM CDT
Domestic ethanol margins have grown with decreasing corn prices over the past few years, but the days of cheap feedstock may soon be a thing of the past. American biofuel companies reliant on domestic corn and oilseeds along with advanced biofuel...
Amyris Biorefinery Successfully Restarts Industrial Production in Brazil
GlobeNewswire - Wed Apr 16, 7:15AM CDT
Amyris, Inc. (Nasdaq:AMRS), the leading synthetic biology innovator and renewable products company, today announced its industrial fermentation plant, located in the town of Brotas in southeastern Brazil, has successfully resumed industrial production following a planned maintenance period.
What Makes Amyris (AMRS) a Strong Sell? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Apr 14, 7:44AM CDT
Amyris (AMRS) has witnessed a significant price decline in the past four weeks, and it has seen negative earnings estimate revisions for the current year.
Hot Stock: Amyris, Shares Drop 6.3% (AMRS)
Comtex SmarTrend(R) - Thu Apr 10, 12:46PM CDT
Amyris (NASDAQ:AMRS) is one of today's worst performing low-priced stocks, down 6.3% to $3.71 on 1.0x average daily volume. Amyris has traded 918,000 shares thus far today, vs. average volume of 909,000 shares per day. The stock has underperformed the Dow (-6.3% to the Dow's -1.2%) and underperformed the S&P 500 (-6.3% to the S&P's -1.6%) during today's trading.
Commit To Purchase Amyris At $2.50, Earn 8.8% Annualized Using Options
StockOptionsChannel.com - Mon Apr 07, 10:42AM CDT
Investors considering a purchase of Amyris, Inc. shares, but tentative about paying the going market price of $4.10/share, might benefit from considering selling puts among the alternative strategies at their disposal.
Amyris to Begin Selling Biofene Online at Farnesene.net
GlobeNewswire - Fri Apr 04, 7:00AM CDT
Amyris, Inc. (Nasdaq:AMRS), a leading synthetic biology innovator and renewable products company, today announced it has begun selling Biofene(R), Amyris's brand of farnesene, a long-chain branched hydrocarbon, online at farnesene.net. By making initial quantities of its building block molecule available to a broader audience, Amyris seeks to expand Biofene's use beyond the commercial applications the Company and its partners are already developing.
Joint Venture Facilities, Agreement Terminations, Promotions, Appointments, and Collaboration Expansions - Analyst Notes on Dow, Cameco, Ultra, AngloGold Ashanti, and Amyris
PR Newswire - Fri Apr 04, 7:00AM CDT
Today, Analysts Review released its analysts' notes regarding The Dow Chemical Company (NYSE: DOW), Cameco Corp. (NYSE: CCJ), Ultra Petroleum Corp. (NYSE: UPL), AngloGold Ashanti Ltd. (NYSE: AU), and Amyris, Inc. (NASDAQ: AMRS). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.AnalystsReview.com/register
Amyris signs strain engineering collaboration with Amyris
M2 - Fri Apr 04, 4:50AM CDT
US-based renewable products company Amyris (NasdaqGS:AMRS) reported on Thursday the launch of a collaborative research and development agreement for its strain engineering technology with BASF SE (XETRA:BAS.DE).
Nasdaq stocks posting largest volume increases
AP - Thu Apr 03, 5:24PM CDT
NEW YORK (AP) — A look at the 10 biggest volume gainers on Nasdaq at the close of trading:
Traders Get Bullish on Shares of Amyris, Shares Up 18.9% (AMRS)
Comtex SmarTrend(R) - Thu Apr 03, 10:10AM CDT
Amyris (NASDAQ:AMRS) is one of today's best performing low-priced stocks, up 18.9% to $4.79 on 5.4x average daily volume. Amyris has traded 3.4 million shares thus far today, vs. average volume of 617,000 shares per day. The stock has outperformed the Dow (18.9% to the Dow's -0.1%) and outperformed the S&P 500 (18.9% to the S&P's -0.1%) during today's trading.
Why Amyris Inc's Shares Popped Today
Travis Hoium, The Motley Fool - Motley Fool - Fri May 09, 5:24PM CDT
Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis. What: Shares of renewable products company Amyris Inc ...
Amyris Reports First Quarter 2014 Financial Results
GlobeNewswire - Thu May 08, 3:48PM CDT
-- Strong operating performance with combined inflows from product sales and collaboration inflows of $17.9 million
Amyris Receives Roundtable on Sustainable Biomaterials (RSB) Sustainability Certification
GlobeNewswire - Wed May 07, 9:14AM CDT
Amyris, Inc. (Nasdaq:AMRS) has completed the Roundtable on Sustainable Biomaterials (RSB) certification process and has earned one of the most respected sustainability certifications in the world.
What Will Amyris Gain and Sacrifice to Court Tire Manufacturers for Expansion?
Maxx Chatsko, The Motley Fool - Motley Fool - Thu May 01, 1:00PM CDT
A worker stands next to 200,000 liter fermenters at a biorefinery in Brotas, Brazil. Source: Amyris I recently introduced the opportunity presented by the tire industry for the synthetic biology platform under development by Amyris and partner...
Amyris Helps Launch Brazilian Industrial Biotech Association
GlobeNewswire - Wed Apr 30, 4:14PM CDT
A group of the world's leading industrial biotechnology companies, including Amyris (Nasdaq:AMRS), joined forces yesterday to form the Brazilian Industrial Biotechnology Association (in Portuguese ABBI - Associacão Brasileira de Biotecnologia Industrial). This new trade association brings together companies and institutions developing and using microorganisms and its derivatives to deliver renewable products for industries and consumers worldwide. ABBI's primary objective is to foster a dialogue within Brazilian society about the advancements of industrial biotechnology in Brazil. The founding members of ABBI are Amyris, BASF, BioChemtex, BP, Centro de Tecnologia Canavieira, Dow, DSM, DuPont, GranBio, Novozymes, Raizen and Rhodia.
Amyris Is Giving the "Hippie Perfume Molecule" a Synthetic Biology Makeover
Maxx Chatsko, The Motley Fool - Motley Fool - Thu Apr 24, 10:15AM CDT
The patchouli plant, grown for centuries in tropical Asia for use in perfumes, is due for a makeover. Source: Wikimedia Commons / Vieux jardin botanique de Göttingen . Patchouli is fun to say and more fun to spray. While Urban Dictionary...
Amyris to Announce First Quarter Financial Results on Thursday, May 8, 2014
GlobeNewswire - Wed Apr 23, 7:01AM CDT
Amyris, Inc. (Nasdaq:AMRS) will report financial results for the first quarter ended March 31, 2014 after market close on Thursday, May 8, 2014.
Global Synthetic Biology Market 2013-2019 - Genome Engineering, DNA Sequencing, Bioinformatics & Biological Components and Integrated Systems
M2 - Tue Apr 22, 5:30AM CDT
Research and Markets (http://www.researchandmarkets.com/research/29nxfg/synthetic_biology) has announced the addition of the "Synthetic Biology Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast,2013 - 2019" report to their offering. Synthetic biology is a synergistic combination of biology and engineering for the construction of artificial biological system in order to gain desired functions (i.e. to reduce cost or improve efficacy). It comprises nascent technologies that enable synthesis of novel biological parts and organisms that are used in the field of healthcare, chemicals, agriculture and others (biosecurity, R&D and energy and environment). The synthetic biology market is witnessing rapid growth owing to increase in demand for renewable fuels and bio-based chemicals and inexpensive drugs and vaccines that utilizes synthetic biology technologies and products. In addition, participation of various organizations such as BioBricks, DIYbio and SynBERC, for the development of synthetic biology field will further augment the growth of this market during the forecast period. However, high cost and strict regulations to use synthetic biology techniques hampers the growth of this market. Synthetic biology market is segmented mainly by products, by technologies and by applications. Synthetic biology, by product segment is classified as core products and enabling products. Core products are further segmented into synthetic DNA, synthetic genes, synthetic cells, XNA and chassis organisms. The synthetic biology market by core products was dominated by synthetic DNA market in 2012 owing to the commercial availability of this product, compared to other synthetic core products expected to be launched in the market in coming years. Synthetic biology market by technologies is segmented as genome engineering, DNA sequencing, bioinformatics and biological components and integrated systems. Genome engineering technology can be used to modify genetic foods, gene cloning and gene therapy. Thus, application of genome engineering increases the scope to utilize this technique and hence accentuates the growth of this market. Applications of synthetic biology are healthcare, chemicals, agriculture and others. Synthetic biology in healthcare holds largest market share in terms of revenue due to high utilization of synthetic biology techniques to produce cheap drugs and vaccines. Also, commercial availability of synthetic DNA and synthetic genes supports the growth of the healthcare application in the synthetic biology market. Agriculture segment is expected to grow at the highest growth rate during the forecast period. The global synthetic biology market is segmented into the following categories: Products - Core Products - - Synthetic DNA - - Synthetic Genes - - Synthetic Cells - - XNA (Xeno Nucleic Acid) - - Chasis Organisms - Enabling Products - - DNA Synthesis - - Oligonucleotide Synthesis Technologies - Genome Engineering - DNA Sequencing - Bioinformatics - Biological Components and Integrated Systems Applications - Healthcare - Chemicals (Including Bio-Fuels) - Agriculture - Others (Biosecurity, R&D, Energy and Environment) Key Topics Covered: - Introduction - Executive Summary - Market Overview - Global Synthetic Biology Market, by Products - Global Synthetic Biology Market, by Technologies - Global Synthetic Biology Market, by Applications - Global Synthetic Biology Market, by Geography - Competitive Landscape - Recommendations - Company Profiles - Agrivida, Inc. - Amyris, Inc. - Algenol Biofuels, Inc. - ATG:biosynthetics GmbH - Bayer AG - Bristol-Myers Squibb - BIONEER CORPORATION - Biosearch Technologies, Inc. - CBC Comprehensive Biomarker Center GmbH - Cobalt Technologies - DuPont, Inc. - Evolva SA - Exxon Mobil Corporation - Ginkgo Bioworks - GeneWorks Pty Ltd. - Genomatica, Inc. - GeneScript Corporation - Gevo, Inc. - Green Biologics Limited - New England Biolabs, Inc. - OriGene Technologies, Inc. - REG Life Sciences, LLC - Royal DSM - Thermo Fisher Scientific, Inc. For more information visit http://www.researchandmarkets.com/research/29...ic_biology
Solazyme and Amyris Can Cut Energy Consumption Without Producing a Drop of Fuel
Maxx Chatsko, The Motley Fool - Motley Fool - Sun Apr 20, 12:03PM CDT
Most companies targeting renewable fuels failed fast and hard after the Great Recession, which caused oil prices to plummet from an all-time high of $147 per barrel in July 2008 to a several-year minimum below $40 per barrel in 2009. Oil prices have...
The World's Leading Tire Manufacturers Are Turning to Synthetic Biology -- But Not for the Reason Yo
Maxx Chatsko, The Motley Fool - Motley Fool - Wed Apr 16, 11:45AM CDT
This pile of 1 million tires would produce 55,000 gallons of toxic oil runoff into the environment if set ablaze. Source: Ohio EPA. The U.S. Environmental Protection Agency has made tremendous strides in reducing scrap tire stockpiles in the past...
Rising World Food Prices Spell Trouble for Biofuels
Shamus Funk, The Motley Fool - Motley Fool - Wed Apr 16, 8:43AM CDT
Domestic ethanol margins have grown with decreasing corn prices over the past few years, but the days of cheap feedstock may soon be a thing of the past. American biofuel companies reliant on domestic corn and oilseeds along with advanced biofuel...
Amyris Biorefinery Successfully Restarts Industrial Production in Brazil
GlobeNewswire - Wed Apr 16, 7:15AM CDT
Amyris, Inc. (Nasdaq:AMRS), the leading synthetic biology innovator and renewable products company, today announced its industrial fermentation plant, located in the town of Brotas in southeastern Brazil, has successfully resumed industrial production following a planned maintenance period.
What Makes Amyris (AMRS) a Strong Sell? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Apr 14, 7:44AM CDT
Amyris (AMRS) has witnessed a significant price decline in the past four weeks, and it has seen negative earnings estimate revisions for the current year.
Hot Stock: Amyris, Shares Drop 6.3% (AMRS)
Comtex SmarTrend(R) - Thu Apr 10, 12:46PM CDT
Amyris (NASDAQ:AMRS) is one of today's worst performing low-priced stocks, down 6.3% to $3.71 on 1.0x average daily volume. Amyris has traded 918,000 shares thus far today, vs. average volume of 909,000 shares per day. The stock has underperformed the Dow (-6.3% to the Dow's -1.2%) and underperformed the S&P 500 (-6.3% to the S&P's -1.6%) during today's trading.
Commit To Purchase Amyris At $2.50, Earn 8.8% Annualized Using Options
StockOptionsChannel.com - Mon Apr 07, 10:42AM CDT
Investors considering a purchase of Amyris, Inc. shares, but tentative about paying the going market price of $4.10/share, might benefit from considering selling puts among the alternative strategies at their disposal.
Amyris to Begin Selling Biofene Online at Farnesene.net
GlobeNewswire - Fri Apr 04, 7:00AM CDT
Amyris, Inc. (Nasdaq:AMRS), a leading synthetic biology innovator and renewable products company, today announced it has begun selling Biofene(R), Amyris's brand of farnesene, a long-chain branched hydrocarbon, online at farnesene.net. By making initial quantities of its building block molecule available to a broader audience, Amyris seeks to expand Biofene's use beyond the commercial applications the Company and its partners are already developing.
Joint Venture Facilities, Agreement Terminations, Promotions, Appointments, and Collaboration Expansions - Analyst Notes on Dow, Cameco, Ultra, AngloGold Ashanti, and Amyris
PR Newswire - Fri Apr 04, 7:00AM CDT
Today, Analysts Review released its analysts' notes regarding The Dow Chemical Company (NYSE: DOW), Cameco Corp. (NYSE: CCJ), Ultra Petroleum Corp. (NYSE: UPL), AngloGold Ashanti Ltd. (NYSE: AU), and Amyris, Inc. (NASDAQ: AMRS). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.AnalystsReview.com/register
Amyris signs strain engineering collaboration with Amyris
M2 - Fri Apr 04, 4:50AM CDT
US-based renewable products company Amyris (NasdaqGS:AMRS) reported on Thursday the launch of a collaborative research and development agreement for its strain engineering technology with BASF SE (XETRA:BAS.DE).
Nasdaq stocks posting largest volume increases
AP - Thu Apr 03, 5:24PM CDT
NEW YORK (AP) — A look at the 10 biggest volume gainers on Nasdaq at the close of trading:
Traders Get Bullish on Shares of Amyris, Shares Up 18.9% (AMRS)
Comtex SmarTrend(R) - Thu Apr 03, 10:10AM CDT
Amyris (NASDAQ:AMRS) is one of today's best performing low-priced stocks, up 18.9% to $4.79 on 5.4x average daily volume. Amyris has traded 3.4 million shares thus far today, vs. average volume of 617,000 shares per day. The stock has outperformed the Dow (18.9% to the Dow's -0.1%) and outperformed the S&P 500 (18.9% to the S&P's -0.1%) during today's trading.
